Science Abstracts
Decision models for assessing the cost effectiveness of drug-eluting stents
June 2005
June 2005
Authors : David F Kong , Eric L Eisenstein
Affliation : Duke University Medical Centre, Duke Clinical Research Institute, DUMC Box 3850, Durham, NC 27710, USA. kong0008@dcri.duke.edu
DOI : 10.1517/14656566.6.6.965
Published in : Expert Opin. Pharmacother. Volume 6 Issue 6 2005 pages 965 974
Subject: Review
Keywords: angioplasty , coronary disease , computer simulation , cost-benefit analysis , cost-effectiveness , decision model , drug-eluting stent , health insurance reimbursement , hospital costs , percutaneous coronary , transluminal
Abstract
Percutaneous coronary intervention is an increasingly...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Zombies, doomsday and debt ceilings, oh my
- US Capitol Capsule: Obama wants one-stop shop for patents, trade & small biz aid
- US Capitol Capsule: IOM focus on affordable 'essential' benefits expected to stir debate on drug prices
- France votes for more regulatory transparency, tighter safety monitoring and tougher promotion controls
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
